Preclinical Evaluation of an Activity-Based Probe for Intraoperative Imaging of Esophageal Cancer
Open Access
- 14 July 2022
- journal article
- research article
- Published by SAGE Publications in Molecular Imaging
- Vol. 2022, 5447290
Abstract
Background. Early detection and complete resection are important prognostic factors for esophageal cancer (EC). Intraoperative molecular imaging (IMI) using tumor-targeted tracers is effective in many cancer types. However, there are no EC-specific IMI tracers. We sought to test a cathepsin activity-based tracer (VGT-309) for EC resection. Methods. Murine (AKR, HNM007) and human (OE19) EC cell lines were screened for cathepsin expression by western blotting. In vitro binding affinity of VGT-309 was evaluated by fluorescence microscopy. Flank tumor models were developed by injecting EC cells into the flanks of BALB/c or athymic nude mice. Mice pretreated with a cathepsin inhibitor (JPM-OEt) were used to confirm on target binding. Animals were injected with 2mg/kg VGT-309, underwent IMI, and were sacrificed 24 hours after injection. Results. Cathepsins B, L, S, and X were expressed by EC cell lines, and all cell lines were labeled in vitro with VGT-309. Fluorescent signal was eliminated when cells were pretreated with JPM-OEt. On biodistribution analysis, VGT-309 accumulated in the liver, kidneys, and spleen without other organ involvement. VGT-309 selectively accumulated in flank allografts and xenografts, with mean signal-to-background ratio of 5.21 (IQR: 4.18-6.73) for flank allografts and 4.34 (IQR: 3.75-5.02) for flank xenografts. Fluorescence microscopy and histopathological analysis confirmed the selective accumulation of the tracer in tumors compared to background normal tissues. Conclusions. VGT-309 is an effective tracer for IMI of esophageal cancer. There is potential for clinical translation both as an adjunct to endoscopic detection and for complete removal of disease during esophagectomy.Keywords
Funding Information
- State of Pennsylvania Health Research Formula Fund
- Society for Thoracic Surgeons
- National Institutes of Health (P01CA254859)
- American Philosophical Society
This publication has 40 references indexed in Scilit:
- Factors associated with early recurrence and death after esophagectomy for cancerJournal of Surgical Oncology, 2013
- Improved Quenched Fluorescent Probe for Imaging of Cysteine Cathepsin ActivityJournal of the American Chemical Society, 2013
- Topical Application of Activity-based Probes for Visualization of Brain Tumor TissuePLOS ONE, 2012
- Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI EndoscopyTheranostics, 2012
- Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probesNature Chemical Biology, 2007
- multifunctional enzymes in cancerNature Reviews Cancer, 2006
- Dynamic imaging of protease activity with fluorescently quenched activity-based probesNature Chemical Biology, 2005
- Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer CellsJNCI: Journal of the National Cancer Institute, 2004
- Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesisCancer Cell, 2004
- ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancerInternational Journal of Cancer, 1997